Skip to main content
Erschienen in: Journal of Contemporary Psychotherapy 3/2016

30.11.2015 | Original Paper

Words and Drugs: Same Mechanisms of Action?

verfasst von: Alessandro Piedimonte, Fabrizio Benedetti

Erschienen in: Journal of Contemporary Psychotherapy | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

The therapeutic effects of words, rituals and, more in general, of the whole psychosocial context around the patient, have been investigated over the past few years by using the placebo response as a model. Today we are in a good position to study all these complex psychological factors by using a physiological and neuroscientific approach that uses modern neurobiological tools to probe different brain functions. Since a placebo is represented by the whole ritual of the therapeutic act, the main concept that has emerged today is that words and rituals may modulate the same biochemical pathways that are modulated by drugs. Most of our knowledge about these mechanisms comes from the field of pain, and represents a biomedical, psychological and philosophical enterprise that is changing the way we approach and interpret medicine, psychology and human biology. If on the one hand we know some of the mechanisms of drug action in the central nervous system, on the other we can now understand how the therapist’s words may affect different physiological functions. In fact, the placebo effect and the therapist–patient relationship can be approached by using the same biochemical, cellular and physiological tools of the materia medica. Although the responses to the therapist’s words cannot be reduced merely to the action of a single drug, this represents an epochal transition, in which the distinction between psychotherapy and pharmacotherapy is progressively getting thinner, and which helps us overcome the old dichotomy between psychology and biology.
Literatur
Zurück zum Zitat Amanzio, M., & Benedetti, F. (1999). Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. The Journal of Neuroscience, 19(1), 484–494.PubMed Amanzio, M., & Benedetti, F. (1999). Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. The Journal of Neuroscience, 19(1), 484–494.PubMed
Zurück zum Zitat Amanzio, M., Benedetti, F., Porro, C. A., Palermo, S., & Cauda, F. (2013). Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Human Brain Mapping, 34(3), 738–752. doi:10.1002/hbm.21471.PubMed Amanzio, M., Benedetti, F., Porro, C. A., Palermo, S., & Cauda, F. (2013). Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Human Brain Mapping, 34(3), 738–752. doi:10.​1002/​hbm.​21471.PubMed
Zurück zum Zitat Amanzio, M., Pollo, A., Maggi, G., & Benedetti, F. (2001). Response variability to analgesics: A role for non-specific activation of endogenous opioids. Pain, 90(3), 205–215.CrossRefPubMed Amanzio, M., Pollo, A., Maggi, G., & Benedetti, F. (2001). Response variability to analgesics: A role for non-specific activation of endogenous opioids. Pain, 90(3), 205–215.CrossRefPubMed
Zurück zum Zitat Andre, J., Zeau, B., Pohl, M., Cesselin, F., Benoliel, J.-J., & Becker, C. (2005). Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: Behavioral and biochemical studies. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(35), 7896–7904. doi:10.1523/JNEUROSCI.0743-05.2005.CrossRef Andre, J., Zeau, B., Pohl, M., Cesselin, F., Benoliel, J.-J., & Becker, C. (2005). Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: Behavioral and biochemical studies. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(35), 7896–7904. doi:10.​1523/​JNEUROSCI.​0743-05.​2005.CrossRef
Zurück zum Zitat Benedetti, F. (1996). The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain, 64(3), 535–543.CrossRefPubMed Benedetti, F. (1996). The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain, 64(3), 535–543.CrossRefPubMed
Zurück zum Zitat Benedetti, F. (2010b). The patient’s brain: The neuroscience behind the doctor-patient relationship (1 edizione.). Oxford: Oxford University Press.CrossRef Benedetti, F. (2010b). The patient’s brain: The neuroscience behind the doctor-patient relationship (1 edizione.). Oxford: Oxford University Press.CrossRef
Zurück zum Zitat Benedetti, F. (2014b). Placebo effects. Oxford: Oxford University Press.CrossRef Benedetti, F. (2014b). Placebo effects. Oxford: Oxford University Press.CrossRef
Zurück zum Zitat Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997). Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain, 71(2), 135–140.CrossRefPubMed Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997). Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain, 71(2), 135–140.CrossRefPubMed
Zurück zum Zitat Benedetti, F., Amanzio, M., & Maggi, G. (1995). Potentiation of placebo analgesia by proglumide. Lancet (London, England), 346(8984), 1231.CrossRef Benedetti, F., Amanzio, M., & Maggi, G. (1995). Potentiation of placebo analgesia by proglumide. Lancet (London, England), 346(8984), 1231.CrossRef
Zurück zum Zitat Benedetti, F., Amanzio, M., Rosato, R., & Blanchard, C. (2011a). Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature Medicine, 17(10), 1228–1230. doi:10.1038/nm.2435.CrossRefPubMed Benedetti, F., Amanzio, M., Rosato, R., & Blanchard, C. (2011a). Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature Medicine, 17(10), 1228–1230. doi:10.​1038/​nm.​2435.CrossRefPubMed
Zurück zum Zitat Benedetti, F., Amanzio, M., & Thoen, W. (2011b). Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology (Berl), 213(4), 791–797. doi:10.1007/s00213-010-2037-y.CrossRef Benedetti, F., Amanzio, M., & Thoen, W. (2011b). Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology (Berl), 213(4), 791–797. doi:10.​1007/​s00213-010-2037-y.CrossRef
Zurück zum Zitat Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006a). The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(46), 12014–12022. doi:10.1523/JNEUROSCI.2947-06.2006.CrossRef Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006a). The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(46), 12014–12022. doi:10.​1523/​JNEUROSCI.​2947-06.​2006.CrossRef
Zurück zum Zitat Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., & Asteggiano, G. (2006b). Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain, 121(1–2), 133–144. doi:10.1016/j.pain.2005.12.016.CrossRefPubMed Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., & Asteggiano, G. (2006b). Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain, 121(1–2), 133–144. doi:10.​1016/​j.​pain.​2005.​12.​016.CrossRefPubMed
Zurück zum Zitat Benedetti, F., Colloca, L., Torre, E., Lanotte, M., Melcarne, A., Pesare, M., et al. (2004b). Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nature Neuroscience, 7(6), 587–588. doi:10.1038/nn1250.CrossRefPubMed Benedetti, F., Colloca, L., Torre, E., Lanotte, M., Melcarne, A., Pesare, M., et al. (2004b). Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nature Neuroscience, 7(6), 587–588. doi:10.​1038/​nn1250.CrossRefPubMed
Zurück zum Zitat Benedetti, F., Maggi, G., Lopiano, L., Lanotte, M., Rainero, I., Vighetti, S., & Pollo, A. (2003a). Open versus hidden medical treatments: The patient’s knowledge about a therapy affects the therapy outcome. Prevention & Treatment,. doi:10.1037/1522-3736.6.1.61a. Benedetti, F., Maggi, G., Lopiano, L., Lanotte, M., Rainero, I., Vighetti, S., & Pollo, A. (2003a). Open versus hidden medical treatments: The patient’s knowledge about a therapy affects the therapy outcome. Prevention & Treatment,. doi:10.​1037/​1522-3736.​6.​1.​61a.
Zurück zum Zitat Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003b). Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(10), 4315–4323. Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003b). Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(10), 4315–4323.
Zurück zum Zitat Bingel, U., Wanigasekera, V., Wiech, K., Ni Mhuircheartaigh, R., Lee, M. C., Ploner, M., & Tracey, I. (2011). The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Science Translational Medicine, 3(70), 70ra14. doi:10.1126/scitranslmed.3001244.CrossRefPubMed Bingel, U., Wanigasekera, V., Wiech, K., Ni Mhuircheartaigh, R., Lee, M. C., Ploner, M., & Tracey, I. (2011). The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Science Translational Medicine, 3(70), 70ra14. doi:10.​1126/​scitranslmed.​3001244.CrossRefPubMed
Zurück zum Zitat De la Fuente-Fernández, R., Phillips, A. G., Zamburlini, M., Sossi, V., Calne, D. B., Ruth, T. J., & Stoessl, A. J. (2002). Dopamine release in human ventral striatum and expectation of reward. Behavioural Brain Research, 136(2), 359–363.CrossRefPubMed De la Fuente-Fernández, R., Phillips, A. G., Zamburlini, M., Sossi, V., Calne, D. B., Ruth, T. J., & Stoessl, A. J. (2002). Dopamine release in human ventral striatum and expectation of reward. Behavioural Brain Research, 136(2), 359–363.CrossRefPubMed
Zurück zum Zitat De la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001). Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science (New York, N.Y.), 293(5532), 1164–1166. doi:10.1126/science.1060937.CrossRef De la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001). Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science (New York, N.Y.), 293(5532), 1164–1166. doi:10.​1126/​science.​1060937.CrossRef
Zurück zum Zitat Eippert, F., Finsterbusch, J., Bingel, U., & Büchel, C. (2009b). Direct evidence for spinal cord involvement in placebo analgesia. Science (New York, N.Y.), 326(5951), 404. doi:10.1126/science.1180142.CrossRef Eippert, F., Finsterbusch, J., Bingel, U., & Büchel, C. (2009b). Direct evidence for spinal cord involvement in placebo analgesia. Science (New York, N.Y.), 326(5951), 404. doi:10.​1126/​science.​1180142.CrossRef
Zurück zum Zitat Faria, V., Ahs, F., Appel, L., Linnman, C., Bani, M., Bettica, P., et al. (2014). Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 17(8), 1149–1157. doi:10.1017/S1461145714000352.CrossRef Faria, V., Ahs, F., Appel, L., Linnman, C., Bani, M., Bettica, P., et al. (2014). Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 17(8), 1149–1157. doi:10.​1017/​S146114571400035​2.CrossRef
Zurück zum Zitat Frisaldi, E., Carlino, E., Lanotte, M., Lopiano, L., & Benedetti, F. (2014). Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients. Cortex; A Journal Devoted to the Study of the Nervous System and Behavior, 60, 3–9. doi:10.1016/j.cortex.2013.12.003.CrossRefPubMed Frisaldi, E., Carlino, E., Lanotte, M., Lopiano, L., & Benedetti, F. (2014). Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients. Cortex; A Journal Devoted to the Study of the Nervous System and Behavior, 60, 3–9. doi:10.​1016/​j.​cortex.​2013.​12.​003.CrossRefPubMed
Zurück zum Zitat Furmark, T., Appel, L., Henningsson, S., Ahs, F., Faria, V., Linnman, C., et al. (2008). A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 28(49), 13066–13074. doi:10.1523/JNEUROSCI.2534-08.2008.CrossRef Furmark, T., Appel, L., Henningsson, S., Ahs, F., Faria, V., Linnman, C., et al. (2008). A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 28(49), 13066–13074. doi:10.​1523/​JNEUROSCI.​2534-08.​2008.CrossRef
Zurück zum Zitat Goebel, M. U., Trebst, A. E., Steiner, J., Xie, Y. F., Exton, M. S., Frede, S., et al. (2002). Behavioral conditioning of immunosuppression is possible in humans. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 16(14), 1869–1873. doi:10.1096/fj.02-0389com.CrossRef Goebel, M. U., Trebst, A. E., Steiner, J., Xie, Y. F., Exton, M. S., Frede, S., et al. (2002). Behavioral conditioning of immunosuppression is possible in humans. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 16(14), 1869–1873. doi:10.​1096/​fj.​02-0389com.CrossRef
Zurück zum Zitat Gracely, R. H., Dubner, R., Wolskee, P. J., & Deeter, W. R. (1983). Placebo and Naloxone can Alter Post-surgical Pain by Separate Mechanisms. Nature, 306(5940), 264–265.CrossRefPubMed Gracely, R. H., Dubner, R., Wolskee, P. J., & Deeter, W. R. (1983). Placebo and Naloxone can Alter Post-surgical Pain by Separate Mechanisms. Nature, 306(5940), 264–265.CrossRefPubMed
Zurück zum Zitat Jensen, K. B., Kaptchuk, T. J., Kirsch, I., Raicek, J., Lindstrom, K. M., Berna, C., et al. (2012). Nonconscious activation of placebo and nocebo pain responses. Proceedings of the National Academy of Sciences, 109(39), 15959–15964. doi:10.1073/pnas.1202056109.CrossRef Jensen, K. B., Kaptchuk, T. J., Kirsch, I., Raicek, J., Lindstrom, K. M., Berna, C., et al. (2012). Nonconscious activation of placebo and nocebo pain responses. Proceedings of the National Academy of Sciences, 109(39), 15959–15964. doi:10.​1073/​pnas.​1202056109.CrossRef
Zurück zum Zitat Kong, J., Gollub, R. L., Rosman, I. S., Webb, J. M., Vangel, M. G., Kirsch, I., & Kaptchuk, T. J. (2006). Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(2), 381–388. doi:10.1523/JNEUROSCI.3556-05.2006.CrossRef Kong, J., Gollub, R. L., Rosman, I. S., Webb, J. M., Vangel, M. G., Kirsch, I., & Kaptchuk, T. J. (2006). Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(2), 381–388. doi:10.​1523/​JNEUROSCI.​3556-05.​2006.CrossRef
Zurück zum Zitat Kong, J., Kaptchuk, T. J., Polich, G., Kirsch, I., & Gollub, R. L. (2007). Placebo analgesia: findings from brain imaging studies and emerging hypotheses. Reviews in the Neurosciences, 18(3–4), 173–190.PubMed Kong, J., Kaptchuk, T. J., Polich, G., Kirsch, I., & Gollub, R. L. (2007). Placebo analgesia: findings from brain imaging studies and emerging hypotheses. Reviews in the Neurosciences, 18(3–4), 173–190.PubMed
Zurück zum Zitat Lanotte, M., Lopiano, L., Torre, E., Bergamasco, B., Colloca, L., & Benedetti, F. (2005). Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain, Behavior, and Immunity, 19(6), 500–509. doi:10.1016/j.bbi.2005.06.004.CrossRefPubMed Lanotte, M., Lopiano, L., Torre, E., Bergamasco, B., Colloca, L., & Benedetti, F. (2005). Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain, Behavior, and Immunity, 19(6), 500–509. doi:10.​1016/​j.​bbi.​2005.​06.​004.CrossRefPubMed
Zurück zum Zitat Leuchter, A. F., McCracken, J. T., Hunter, A. M., Cook, I. A., & Alpert, J. E. (2009). Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. Journal of Clinical Psychopharmacology, 29(4), 372–377. doi:10.1097/JCP.0b013e3181ac4aaf.CrossRefPubMed Leuchter, A. F., McCracken, J. T., Hunter, A. M., Cook, I. A., & Alpert, J. E. (2009). Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. Journal of Clinical Psychopharmacology, 29(4), 372–377. doi:10.​1097/​JCP.​0b013e3181ac4aaf​.CrossRefPubMed
Zurück zum Zitat Levine, J. D., & Gordon, N. C. (1984). Influence of the method of drug administration on analgesic response. Nature, 312(5996), 755–756.CrossRefPubMed Levine, J. D., & Gordon, N. C. (1984). Influence of the method of drug administration on analgesic response. Nature, 312(5996), 755–756.CrossRefPubMed
Zurück zum Zitat Levine, J. D., Gordon, N. C., & Fields, H. L. (1978). The mechanism of placebo analgesia. Lancet (London, England), 2(8091), 654–657.CrossRef Levine, J. D., Gordon, N. C., & Fields, H. L. (1978). The mechanism of placebo analgesia. Lancet (London, England), 2(8091), 654–657.CrossRef
Zurück zum Zitat Levine, J. D., Gordon, N. C., Smith, R., & Fields, H. L. (1981). Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain, 10(3), 379–389.CrossRefPubMed Levine, J. D., Gordon, N. C., Smith, R., & Fields, H. L. (1981). Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain, 10(3), 379–389.CrossRefPubMed
Zurück zum Zitat Meissner, K., Bingel, U., Colloca, L., Wager, T. D., Watson, A., & Flaten, M. A. (2011). The placebo effect: advances from different methodological approaches. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(45), 16117–16124. doi:10.1523/JNEUROSCI.4099-11.2011.CrossRef Meissner, K., Bingel, U., Colloca, L., Wager, T. D., Watson, A., & Flaten, M. A. (2011). The placebo effect: advances from different methodological approaches. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(45), 16117–16124. doi:10.​1523/​JNEUROSCI.​4099-11.​2011.CrossRef
Zurück zum Zitat Pacheco-López, G., Niemi, M.-B., Kou, W., Härting, M., Fandrey, J., & Schedlowski, M. (2005). Neural substrates for behaviorally conditioned immunosuppression in the rat. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(9), 2330–2337. doi:10.1523/JNEUROSCI.4230-04.2005.CrossRef Pacheco-López, G., Niemi, M.-B., Kou, W., Härting, M., Fandrey, J., & Schedlowski, M. (2005). Neural substrates for behaviorally conditioned immunosuppression in the rat. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(9), 2330–2337. doi:10.​1523/​JNEUROSCI.​4230-04.​2005.CrossRef
Zurück zum Zitat Peciña, M., Martínez-Jauand, M., Hodgkinson, C., Stohler, C. S., Goldman, D., & Zubieta, J. K. (2014). FAAH selectively influences placebo effects. Molecular Psychiatry, 19(3), 385–391. doi:10.1038/mp.2013.124.CrossRefPubMed Peciña, M., Martínez-Jauand, M., Hodgkinson, C., Stohler, C. S., Goldman, D., & Zubieta, J. K. (2014). FAAH selectively influences placebo effects. Molecular Psychiatry, 19(3), 385–391. doi:10.​1038/​mp.​2013.​124.CrossRefPubMed
Zurück zum Zitat Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002). Placebo and opioid analgesia– imaging a shared neuronal network. Science (New York, N.Y.), 295(5560), 1737–1740. doi:10.1126/science.1067176.CrossRef Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002). Placebo and opioid analgesia– imaging a shared neuronal network. Science (New York, N.Y.), 295(5560), 1737–1740. doi:10.​1126/​science.​1067176.CrossRef
Zurück zum Zitat Pollo, A., Torre, E., Lopiano, L., Rizzone, M., Lanotte, M., Cavanna, A., et al. (2002). Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. NeuroReport, 13(11), 1383–1386.CrossRefPubMed Pollo, A., Torre, E., Lopiano, L., Rizzone, M., Lanotte, M., Cavanna, A., et al. (2002). Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. NeuroReport, 13(11), 1383–1386.CrossRefPubMed
Zurück zum Zitat Price, D. D., Craggs, J., Verne, G. N., Perlstein, W. M., & Robinson, M. E. (2007). Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain, 127(1–2), 63–72. doi:10.1016/j.pain.2006.08.001.CrossRefPubMed Price, D. D., Craggs, J., Verne, G. N., Perlstein, W. M., & Robinson, M. E. (2007). Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain, 127(1–2), 63–72. doi:10.​1016/​j.​pain.​2006.​08.​001.CrossRefPubMed
Zurück zum Zitat Price, D. D., Craggs, J. G., Zhou, Q., Verne, G. N., Perlstein, W. M., & Robinson, M. E. (2008). Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. NeuroImage, 47(3), 995–1001. doi:10.1016/j.neuroimage.2009.04.028.CrossRef Price, D. D., Craggs, J. G., Zhou, Q., Verne, G. N., Perlstein, W. M., & Robinson, M. E. (2008). Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. NeuroImage, 47(3), 995–1001. doi:10.​1016/​j.​neuroimage.​2009.​04.​028.CrossRef
Zurück zum Zitat Stein, N., Sprenger, C., Scholz, J., Wiech, K., & Bingel, U. (2012). White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain, 153(11), 2210–2217. doi:10.1016/j.pain.2012.07.010.CrossRefPubMed Stein, N., Sprenger, C., Scholz, J., Wiech, K., & Bingel, U. (2012). White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain, 153(11), 2210–2217. doi:10.​1016/​j.​pain.​2012.​07.​010.CrossRefPubMed
Zurück zum Zitat Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., et al. (2003). Dynamics of gray matter loss in Alzheimer’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(3), 994–1005. Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., et al. (2003). Dynamics of gray matter loss in Alzheimer’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(3), 994–1005.
Zurück zum Zitat Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Zhu, W., Maynard, L., et al. (2003). Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(36), 11461–11468. Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Zhu, W., Maynard, L., et al. (2003). Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(36), 11461–11468.
Zurück zum Zitat Wager, T. D., Atlas, L. Y., Leotti, L. A., & Rilling, J. K. (2011). Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(2), 439–452. doi:10.1523/JNEUROSCI.3420-10.2011.CrossRef Wager, T. D., Atlas, L. Y., Leotti, L. A., & Rilling, J. K. (2011). Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(2), 439–452. doi:10.​1523/​JNEUROSCI.​3420-10.​2011.CrossRef
Zurück zum Zitat Wager, T. D., Rilling, J. K., Smith, E. E., Sokolik, A., Casey, K. L., Davidson, R. J., et al. (2004). Placebo-induced changes in FMRI in the anticipation and experience of pain. Science (New York, N.Y.), 303(5661), 1162–1167. doi:10.1126/science.1093065.CrossRef Wager, T. D., Rilling, J. K., Smith, E. E., Sokolik, A., Casey, K. L., Davidson, R. J., et al. (2004). Placebo-induced changes in FMRI in the anticipation and experience of pain. Science (New York, N.Y.), 303(5661), 1162–1167. doi:10.​1126/​science.​1093065.CrossRef
Zurück zum Zitat Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., et al. (2005). Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(34), 7754–7762. doi:10.1523/JNEUROSCI.0439-05.2005.CrossRef Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., et al. (2005). Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(34), 7754–7762. doi:10.​1523/​JNEUROSCI.​0439-05.​2005.CrossRef
Metadaten
Titel
Words and Drugs: Same Mechanisms of Action?
verfasst von
Alessandro Piedimonte
Fabrizio Benedetti
Publikationsdatum
30.11.2015
Verlag
Springer US
Erschienen in
Journal of Contemporary Psychotherapy / Ausgabe 3/2016
Print ISSN: 0022-0116
Elektronische ISSN: 1573-3564
DOI
https://doi.org/10.1007/s10879-015-9321-4

Weitere Artikel der Ausgabe 3/2016

Journal of Contemporary Psychotherapy 3/2016 Zur Ausgabe